We are live on
!
Find out more
GD
Grandfield & Dodd Portfolio holdings
AUM
$1.77B
1-Year Est. Return
23.43%
This Fund
S&P 500
This Quarter
Est. Return
+8.46%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.71B
AUM Growth
+$94.7M
(+5.9%)
Cap. Flow
-$7.02M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
35.58%
Holding
214
New
17
Increased
63
Reduced
81
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$4.75M |
| 2 |
Lamb Weston
LW
|
+$2.95M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.13M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$1.12M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$834K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$6.46M |
| 2 |
GE Vernova
GEV
|
+$3.39M |
| 3 |
Merck
MRK
|
+$2.86M |
| 4 |
Corning
GLW
|
+$2.26M |
| 5 |
Microsoft
MSFT
|
+$1.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Industrials | 19.05% |
| 3 | Healthcare | 14.75% |
| 4 | Financials | 9.62% |
| 5 | Materials | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFUS
201
Dimensional US Equity ETF
DFUS
$20.3B
| $241K | 0.01% |
3,599
-600
| -14% | -$37.2K |
|
202
Northern Trust
NTRS
$21.8B
| $239K | 0.01% |
+1,888
| New | +$193K |
|
203
Texas Instruments
TXN
$248B
| $231K | 0.01% |
+1,112
| New | +$197K |
|
204
Chipotle Mexican Grill
CMG
$43.9B
| $230K | 0.01% |
4,100
-485
| -11% | -$24.7K |
|
|
SCHW
205
Charles Schwab
SCHW
$182B
| $226K | 0.01% |
+2,480
| New | +$208K |
|
206
State Street Industrial Select Sector SPDR ETF
XLI
$32.2B
| $221K | 0.01% |
+1,500
| New | +$205K |
|
207
Markel Group
MKL
$25.2B
| $220K | 0.01% |
+110
| New | +$206K |
|
208
Equinix
EQIX
$99.4B
| $208K | 0.01% |
262
| – | – |
|
209
Genuine Parts
GPC
$17.9B
| $206K | 0.01% |
1,698
| – | – |
|
210
Innospec
IOSP
$2.09B
| $202K | 0.01% |
2,400
| – | – |
|
211
Iovance Biotherapeutics
IOVA
$2.04B
| $157K | 0.01% |
91,075
+100
| +0.1% | +$249 |
|
212
PDS Biotechnology
PDSB
$37.4M
| $13.3K | ﹤0.01% |
+10,000
| New | +$13.6K |
|
|
DFS
213
DELISTED
Discover Financial Services
DFS
| – | – |
-2,376
| Closed | -$406K |
|
214
PNC Financial Services
PNC
$99.1B
| – | – |
-1,218
| Closed | -$214K |
|
Similar funds
HHAM
FFS
KOCAA
CGH
SW
BCMIO
UF
SLF
Grandfield & Dodd's Q2 2025 Portfolio in Review
As of Q2 2025, Grandfield & Dodd held 214 positions worth $1.71B, up 5.9% from $1.61B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Grandfield & Dodd's Q2 2025 filing shows 17 new, 63 increased, 81 reduced and 2 closed positions. Its largest new stake was iShares S&P 500 Growth ETF: 8,430 shares worth $928K. The largest sale was Gilead Sciences, an estimated $6.46M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Industrials and Healthcare.
- Grandfield & Dodd's largest Q2 2025 buy was iShares S&P 500 Growth ETF: 8,430 shares worth $928K.
- Grandfield & Dodd added most to Applied Materials in Q2 2025, an estimated $4.75M increase.
- Grandfield & Dodd's biggest Q2 2025 reduction was Gilead Sciences, cutting an estimated $6.46M.
- Grandfield & Dodd fully exited Discover Financial Services in Q2 2025, selling an estimated $406K.
- Grandfield & Dodd's ten largest holdings make up 36% of its $1.71B portfolio in Q2 2025.
- Grandfield & Dodd opened 17 new positions and closed 2 in Q2 2025.
- Grandfield & Dodd's portfolio value rose 5.9% quarter-over-quarter to $1.71B.
Based on Grandfield & Dodd's 13F filing for Q2 2025, filed 8 Aug 2025.